Michigan Diagnostics
Manufacturer and developer of diagnostic reagents and kits for research and clinical applications. Core activities include formulation and production of chemiluminescent substrates and assay kits (ELISA, western blot), expansion into CLIA and rapid diagnostic kits, and collaboration with partners for development and manufacturing. The company holds intellectual property and states its products carry regulatory approvals (U.S. FDA, Chinese FDA, or CE marking).
Industries
Nr. of Employees
small (1-50)
Michigan Diagnostics
Royal Oak, Michigan, United States, North America
Products
Chemiluminescent ELISA substrate (high-sensitivity)
Substrate formulations designed for chemiluminescent ELISA detection with enhanced sensitivity.
Chemiluminescent western blot substrate (sensitivity/extended signal)
Substrate formulations tuned for western blot detection, including options emphasizing sensitivity or extended signal duration.
Low-background chemiluminescent substrate
Formulations optimized to minimize background signal for improved signal-to-noise in assays.
Extended-emission chemiluminescent substrate
Substrate formulations designed to provide an extended plateau of chemiluminescent signal.
ELISA and western blot product lines (standard and enhanced formulations)
Product lines covering ELISA and western blot reagents with formulations for different sensitivity and background-performance needs.
CLIA kits and rapid diagnostic test kits
Kits intended for clinical laboratory use and rapid testing applications.
Chemiluminescent ELISA substrate (high-sensitivity)
Substrate formulations designed for chemiluminescent ELISA detection with enhanced sensitivity.
Chemiluminescent western blot substrate (sensitivity/extended signal)
Substrate formulations tuned for western blot detection, including options emphasizing sensitivity or extended signal duration.
Low-background chemiluminescent substrate
Formulations optimized to minimize background signal for improved signal-to-noise in assays.
Extended-emission chemiluminescent substrate
Substrate formulations designed to provide an extended plateau of chemiluminescent signal.
ELISA and western blot product lines (standard and enhanced formulations)
Product lines covering ELISA and western blot reagents with formulations for different sensitivity and background-performance needs.
CLIA kits and rapid diagnostic test kits
Kits intended for clinical laboratory use and rapid testing applications.
Services
Partnership-based development and manufacturing support for diagnostic kit development and production.
Online ordering of reagents and provision of free samples for prospective users.
Partnership-based development and manufacturing support for diagnostic kit development and production.
Online ordering of reagents and provision of free samples for prospective users.
Expertise Areas
- Diagnostic reagent development
- Chemiluminescent assay development
- ELISA and western blot reagent kits
- Diagnostic kit manufacturing and scale-up
Key Technologies
- Chemiluminescence
- Horseradish peroxidase (HRP) substrate chemistry
- Alkaline phosphatase (AP) substrate chemistry
- ELISA
News & Updates
Filed a first set of patents in 1998 covering modified cyclodextrins and related reagent chemistry.
Expanded production capabilities in 2008 to add biochemistry kits, CLIA kits, and rapid test kits to product offerings.
States that products carry regulatory approvals from authorities such as the U.S. FDA, Chinese FDA, or CE marking.
Filed a first set of patents in 1998 covering modified cyclodextrins and related reagent chemistry.
Expanded production capabilities in 2008 to add biochemistry kits, CLIA kits, and rapid test kits to product offerings.
States that products carry regulatory approvals from authorities such as the U.S. FDA, Chinese FDA, or CE marking.